Balint's syndrome and post-acute brain injury rehabilitation: a case report.

Brain Inj

Department of Neuropsychology, Transitional Learning Center, 1528 Postoffice Street,Galveston, TX 77550, USA.

Published: September 2011

Background: Balint's syndrome includes the clinical symptom triad of simultagnosia, ocular apraxia and optic ataxia. These symptoms, in combination, are rare and can be quite debilitating as they impact visuospatial skills, visual scanning and attentional mechanisms.

Case Study: The literature addressing rehabilitation of individuals with Balint's syndrome is sparse. The current case report describes the outcome of a 58-year old male who presented with Balint's syndrome secondary to severe traumatic brain injury and following completion of a comprehensive post-acute brain injury rehabilitation programme. The patient was 4-months post-injury onset upon admission and received 6 months of rehabilitation services as an inpatient. The patient's comprehensive rehabilitation programme involved a 3-pronged approach including the implementation of (a) compensatory strategies, (b) remediation exercises and (c) transfer of learned skills in multiple environments and situations with implementation of psychoeducation and psychotherapy. Comprehensive neuropsychological and occupational therapy evaluations were performed at admission and at discharge in order to monitor cognitive, affective, neurological and functional change over time.

Conclusions: Neuropsychological test improvements were noted on tasks that assess visuospatial functioning, although most gains were noted for functional and physical abilities.

Download full-text PDF

Source
http://dx.doi.org/10.3109/02699052.2011.585506DOI Listing

Publication Analysis

Top Keywords

balint's syndrome
16
brain injury
12
post-acute brain
8
injury rehabilitation
8
case report
8
rehabilitation programme
8
rehabilitation
5
balint's
4
syndrome post-acute
4
rehabilitation case
4

Similar Publications

Article Synopsis
  • Cardiovascular diseases (CVD) are the top cause of illness and death globally, including in Croatia, often linked to shared risk factors across multiple health disorders.
  • The emerging concept of cardio-renal-metabolic (CKM) syndrome highlights the interconnectedness of heart, kidney, and metabolic health, emphasizing the need to include brain health in patient care.
  • A group of experts aims to incorporate CKM health into a national strategy for preventing chronic diseases, particularly CVD, by creating mandatory guidelines based on professional recommendations.
View Article and Find Full Text PDF

Autoimmune Movement Disorders.

Continuum (Minneap Minn)

August 2024

Objective: This article reviews the clinical and antibody spectrum of autoimmune cerebellar ataxia and other autoimmune movement disorders. It highlights characteristic phenotypes and red flags to the diagnosis and how these rare, but treatable, disorders are integrated into a differential diagnosis.

Latest Developments: An increasing number of neuronal antibodies have been identified in patients with cerebellar ataxia, for example, against Kelch-like protein 11 (KLHL11), seizure-related 6 homolog-like 2, septin-3 and septin-5, or tripartite motif containing protein 9 (TRIM9), TRIM46, and TRIM67.

View Article and Find Full Text PDF

Aim: To evaluate the effects of lipid-lowering medications of different intensities on total, calcified, and non-calcified plaque volumes in patients undergoing serial cardiac computed tomography angiography (CCTA).

Methods: Individuals with chronic coronary syndromes from 11 centers were included in a retrospective registry. Total, calcified, and non-calcified plaque volumes were quantified and the relative difference in plaque volumes between baseline and follow-up CCTA was calculated.

View Article and Find Full Text PDF

Numerous research projects focused on the management of acute pulmonary hypertension as Coronavirus Disease 2019 (COVID-19) might lead to hypoxia-induced pulmonary vasoconstriction related to acute respiratory distress syndrome. For that reason, inhalative therapeutic options have been the subject of several clinical trials. In this experimental study, we aimed to examine the hemodynamic impact of the inhalation of the SIN-1A formulation (N-nitroso-N-morpholino-amino-acetonitrile, the unstable active metabolite of molsidomine, stabilized by a cyclodextrin derivative) in a porcine model of acute pulmonary hypertension.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!